About
- Name
- E Fund Hang Seng SCHK Innovative Drug ETF
- Index tracked
- Hang Seng SCHK Innovative Drug PR CNY
- Type
- Equity
- Expense ratio
- --
- Management fee
- 0.15%
- Dividend policy
- Monthly
- NAV
- CNY 1.1589 (09/08/2026)
- Issued units
- 5.32B (09/08/2026)
- Listing date
- Mar 18, 2025
- Sponsor
- E Fund Mgmt Co.,Ltd
- Custodian
- China Merchants Bank
ETF Documents
Last updatedType
03/31/2026Annual Report
09/01/2026Semi Annual Report
03/06/2026Prospectus
07/21/2026Quarterly Report